Bojian Ye
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Oral administration of sophoricoside (SOP) inhibits neuronal damage and neuroinflammation to curb neurodegeneration in Parkinson's disease.
Journal: Chemico-biological interactions
Published: May 06, 2023
Oral administration of Limonin (LM) exerts neuroprotective effects by inhibiting neuron autophagy and microglial activation in 6-OHDA-injected rats.
Journal: International immunopharmacology
Published: April 28, 2023
Notopterol inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf2/HO-1 signaling axis.
Journal: International immunopharmacology
Published: January 30, 2023
Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis.
Journal: Journal of agricultural and food chemistry
Published: August 16, 2022
Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.
Journal: Journal of neuroinflammation
Published: June 10, 2022
Hordenine inhibits neuroinflammation and exerts neuroprotective effects via inhibiting NF-κB and MAPK signaling pathways in vivo and in vitro.
Journal: International immunopharmacology
Published: November 28, 2021
Echinocystic Acid Inhibits Inflammation and Exerts Neuroprotective Effects in MPTP-Induced Parkinson's Disease Model Mice.
Journal: Frontiers in pharmacology
Published: October 04, 2021
Menthol Targeting AMPK Alleviates the Inflammatory Response of Bovine Mammary Epithelial Cells and Restores the Synthesis of Milk Fat and Milk Protein.
Journal: Frontiers in immunology
Published: September 25, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026